Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Description

Leading researchers, from the Novartis group that pioneered Gleevec/Glivec™ and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating "selective" low molecular-weight kinase inhibitors; an analysis of the normal function, role in disease, and application of platelet-derived growth factor antagonists; and a summary of the factors involved in successful structure-based drug design. Additional chapters address the advantages and disadvantages of in vivo preclinical models for testing protein kinase inhibitors with antitumor activity and the utility of different methods in the drug discovery and development process for determining "on-target" vs "off-target" effects of kinase inhibitors.

Disclaimer:
Contents of this page are indexed from the Internet. All actions are under your responsability. Email us to report illegal contents or external links and we'll remove them immediately.

Please check the description for download links if any or do a search to find alternative books.

Can't Download?
Please search mirrors if you can't find download links for "Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)" in "Description" and someone else may update the links. Check the comments when back to find any updates.

Search Mirrors
Maybe some mirror pages will be helpful, search this book at top of this page or click here to find more info.

1. Ebooks list page : 2355
2. Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)
3. Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
4. Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
5. Farnesyltransferase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
6. Proteasome Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
7. Inhibitors of Protein Kinases and Protein Phosphates (Repost)
8. Inhibitors of Protein Kinases and Protein Phosphates
9. Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development
10. Cancer Drug Resistance (Cancer Drug Discovery and Development)
11. Cancer Drug Resistance (Cancer Drug Discovery and Development)
12. Cancer Drug Resistance (Cancer Drug Discovery and Development)
13. Combination Cancer Therapy Modulators and Potentiators (Cancer Drug Discovery and Development)
14. EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development)
15. Genomics in Cancer Drug Discovery and Development, Volume 96 (Advances in Cancer Research)
16. Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)